Multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in patients with post-resection melanoma at high risk of recurrence
一项针对术后复发风险高的黑色素瘤患者的多中心、双盲、安慰剂对照试验,研究了seviprotimut-L多价黑色素瘤疫苗的疗效。
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.3
doi:10.1136/jitc-2021-003272.
Craig L Slingluff,Karl D Lewis,Robert Andtbacka,John Hyngstrom,Mohammed Milhem,Svetomir N Markovic,Tawnya Bowles,Omid Hamid,Leonel Hernandez-Aya,Joel Claveau,Sekwon Jang,Prejesh Philips,Shernan G Holtan,Montaser F Shaheen,Brendan Curti,William Schmidt,Marcus O Butler,Juan Paramo,Jose Lutzky,Arvinda Padmanabhan,Sajeve Thomas,Daniel Milton,Andrew Pecora,Takami Sato,Eddy Hsueh,Suprith Badarinath,John Keech,Sujith Kalmadi,Pallavi Kumar,Robert Weber,Edward Levine,Adam Berger,Anna Bar,J Thaddeus Beck,Jeffrey B Travers,Catalin Mihalcioiu,Brian Gastman,Peter Beitsch,Suthee Rapisuwon,Vinay Gupta,Deepti Behl,Brent Blumenstein,Joanna J Peterkin